2m 2m 2m 2m 2m 2m 2m
APOGEE THERAP (APGE)
NASDAQ
$133.52-$0.30 (-0.22%)
Price as of Jul 14, 2026 4:03 AM EDT- $8.3BMarket Cap
- 244.19%1-Year Change
- BiotechnologyIndustry
APOGEE THERAP (APGE)
$133.52-$0.30 (-0.22%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 16.70% | 10.3M | +7.6M (+73.47%) | Mar 31, 2026 |
FMR LLC | 15.01% | 9.3M | +1.0M (+11.20%) | Mar 31, 2026 |
VR ADVISER, LLC | 13.77% | 8.5M | 0 (0.00%) | Mar 31, 2026 |
WELLINGTON MANAGEMENT GROUP LLP | 7.09% | 4.4M | -370,882 (-8.48%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.62% | 4.1M | +301,657 (+7.38%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 4.94% | 3.0M | +69,041 (+2.27%) | Dec 31, 2024 |
VANGUARD GROUP INC | 4.63% | 2.9M | +612,193 (+21.42%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD SPECIALIZED FUNDS | 2.42% | 1.5M | -580,216 (-38.92%) | Apr 30, 2026 |
FIDELITY SECURITIES FUND | 2.08% | 1.3M | +167,813 (+13.05%) | Apr 30, 2026 |
VANGUARD EXPLORER FUND | 0.86% | 530,576 | 0 (0.00%) | Apr 30, 2026 |
Voya INVESTORS TRUST | 0.85% | 525,313 | +396,004 (+75.38%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 0.82% | 507,955 | +5,900 (+1.16%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.73% | 448,422 | +414,607 (+92.46%) | Apr 30, 2026 |
PENN SERIES FUNDS INC | 0.62% | 380,067 | +286,502 (+75.38%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions399.9M (87.99%)
- Mutual Funds53.1M (11.69%)
- Insiders1.4M (0.32%)
- Other0 (0.00%)
Insider Transactions
- 0.32% (1.4M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 4Number of InsiderSelling (last 12 months)
- $1.7BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
HENDERSON MICHAEL THOMAS Chief Executive Officer | Gift | Jul 10, 2026 | $0.00 | 75,046 | $0.00 | 920,941 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jul 08, 2026 | $2.7M | 20,000 | $133.63 | 995,987 |
Dambkowski Carl Chief Medical Officer | Sell | Jun 22, 2026 | $3.5M | 26,400 | $132.60 | 179,248 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $556,561.70 | 6,770 | $82.21 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $633,598.12 | 7,654 | $82.78 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $90,914.40 | 1,080 | $84.18 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $134,344.63 | 1,577 | $85.19 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $198,852.35 | 2,305 | $86.27 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Jun 10, 2026 | $53,350.46 | 614 | $86.89 | 1.1M |
Fairmount Funds Management LLC | Award | Jun 09, 2026 | $0.00 | 7,657 | $0.00 | 7,657 |
Bollinger Lisa | Award | Jun 09, 2026 | $0.00 | 7,657 | $0.00 | 7,657 |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $1.5M | 17,800 | $82.48 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $166,520.00 | 2,000 | $83.26 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Apr 08, 2026 | $17,000.00 | 200 | $85.00 | 1.1M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $621,287.27 | 8,363 | $74.29 | 1.2M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $615,027.77 | 8,219 | $74.83 | 1.2M |
HENDERSON MICHAEL THOMAS Chief Executive Officer | Sell | Mar 11, 2026 | $259,289.48 | 3,418 | $75.86 | 1.2M |
Dambkowski Carl Chief Medical Officer | Exempt | Mar 04, 2026 | $0.00 | 4,125 | $0.00 | 131,290 |
Dambkowski Carl Chief Medical Officer | Exempt | Mar 04, 2026 | $94,297.50 | 4,125 | $22.86 | 215,273 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $226,814.25 | 3,225 | $70.33 | 212,048 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $149,358.50 | 2,075 | $71.98 | 209,973 |
Dambkowski Carl Chief Medical Officer | Sell | Mar 04, 2026 | $14,652.00 | 200 | $73.26 | 209,773 |
Henderson Jane Chief Financial Officer | Sell | Mar 02, 2026 | $20,481.00 | 300 | $68.27 | 183,071 |
Henderson Jane Chief Financial Officer | Sell | Mar 02, 2026 | $20,829.00 | 300 | $69.43 | 182,771 |
Henderson Jane Chief Financial Officer | Sell | Mar 02, 2026 | $70,027.30 | 994 | $70.45 | 181,777 |
Henderson Jane Chief Financial Officer | Sell | Mar 02, 2026 | $29,093.96 | 406 | $71.66 | 181,371 |
Fairmount Funds Management LLC | Sell | Jan 22, 2026 | $133.5M | 1.8M | $76.30 | 298,647 |
Dambkowski Carl Chief Medical Officer | Exempt | Jan 07, 2026 | $0.00 | 14,025 | $0.00 | 139,540 |
Dambkowski Carl Chief Medical Officer | Exempt | Jan 07, 2026 | $320,611.50 | 14,025 | $22.86 | 231,223 |
Dambkowski Carl Chief Medical Officer | Sell | Jan 07, 2026 | $227,842.02 | 2,954 | $77.13 | 228,269 |